Eli Lilly and Company (LLY) released its Q2 2026 financial results on August 5, 2026, before the market open. The reported earnings per share (EPS) of 8.38 USD beat the analyst estimate of 6.40 USD by 30.9%. Revenue for the quarter was 22974 million USD. The stock price reacted to the release with an increase of 4.86%.
Generated automatically from our data — as of August 12, 2026
Key figures at a glance
Estimate (EPS): 6.40 USD
Reported (EPS): 8.38 USD
Price reaction: +4.9%
Frequently asked questions
Did Eli Lilly and Company beat or miss earnings-per-share expectations?
Eli Lilly and Company beat the analyst estimate of 6.40 USD earnings per share (Q2 2026) by 30.9%, reporting 8.38 USD.
How did Eli Lilly and Company stock react to the earnings report?
Eli Lilly and Company stock rose 4.9% on the trading day following the release.
What was Eli Lilly and Company's revenue in Q2 2026?
Eli Lilly and Company reported revenue of 22,974M USD in Q2 2026.